The 4 analysts offering 12-month price forecasts for InflaRx NV have a median target of 6.24, with a high estimate of 8.41 and a low estimate of 2.10. The median estimate represents a +138.35% increase from the last price of 2.62.
The current consensus among 5 polled investment analysts is to Buy stock in InflaRx NV. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.25
Reporting Date Mar 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.